Training Collections
Musculoskeletal Imaging
Emergency Imaging
PET Imaging
Pediatric Imaging
Training Collections
Musculoskeletal Imaging
Emergency Imaging
PET Imaging
Pediatric Imaging
66 topics, 3 hr. 54 min.
Introduction to Salivary Gland Imaging
10 m.Bell's Palsy
5 m.Innervation of the Parotid Gland – Summary
6 m.Stenson’s Duct – Summary
7 m.Submandibular Gland – Summary
5 m.Submandibular Gland & Wharton's Duct Anatomy
7 m.Wharton’s Duct – Summary
2 m.Sublingual Gland – Summary
6 m.Simple and Plunging Ranula
5 m.Minor Salivary Glands – Summary
2 m.Technique for Salivary Gland Imaging – Summary
8 m.MRI Technique – Case
4 m.Benign Neoplasms – Summary
8 m.Pleomorphic adenoma with Carcinoma Ex Pleomorphic Adenoma
11 m.Pleomorphic Adenoma
5 m.Hard Palate Pleomorphic Adenoma
5 m.Pleomorphic Adenoma – Summary
3 m.Parotid Pleomorphic Adenoma
5 m.Parapharyngeal Space Pleomorphic Adenoma – Case
4 m.Deep Lobe Parotid Gland Pleomorphic Adenoma – Case
5 m.Pleomorphic Adenoma of the Nasal Cavity
4 m.Carcinoma Ex Pleomorphic Adenoma
4 m.Advanced Imaging for Salivary Gland Neoplasms – Summary
4 m.Monomorphic Adenoma – Case
2 m.Prognosis of Pleomorphic Adenoma
4 m.Warthin’s Tumor – Summary
5 m.Warthin's Tumor
4 m.Extraparotid Warthin's Tumor
3 m.Multiple Parotid Masses – Summary
3 m.Onocoytomas – Summary
4 m.Oncocytoma
2 m.Schwannoma of the Intraparotid Facial Nerve
2 m.Malignant Neoplasms – Summary
4 m.Mucoepidermoid Carcinoma
4 m.Parotid Mucoepidermoid Carcinoma
3 m.Malignancy Salivary Neoplasm Features - Summary
2 m.Adenoid Cystic Carcinoma – Summary
5 m.Adenoid Cystic Carcinoma
9 m.Adenoid Cystic Carcinoma of the Tongue
3 m.Perineural Spread – Summary
2 m.Perineural Spread in a Large Cell Undifferentiated Carcinoma
4 m.Parotid Squamous Cell Carcinoma
3 m.Left Parotid Squamous Cell Carcinoma – Case
2 m.Adenocarcinomas – Summary
3 m.Parotid Adenocarcinoma
2 m.Recurrent Parotid Adenocarcinoma
3 m.Parotid Lymphoma - Summary
2 m.Parotid Lymphoma on CT
2 m.Parotid Lymphoma on PET-CT
2 m.Acinic Cell Carcinoma
2 m.Sialolithiasis – Summary
6 m.Submandibular Sialithisis
3 m.Submandibular Saialithiasis on MRI
2 m.Submandibular Sialodocholithiasis and Parotid Sialolithiasis
5 m.Salivary Calcifications and Cysts
2 m.Parotid Sialodocholithiasis and Sialectasia on MRI
2 m.Sjögren’s Syndrome – Summary
5 m.Sjögren’s Syndrome
2 m.Kuttner Lesion – Summary
2 m.Salivary Gland Cysts – Summary
6 m.Lympoepithelial Cyst in HIV
3 m.Sialadenitis in HIV
5 m.Ranulas – Summary
4 m.Bilateral Ranulas
2 m.Ranula - Clinical Correlation
1 m.Sialocele – Summary
4 m.0:01
Oncocytomas are not very common lesions.
0:04
Certainly, the benign lesions of the parotid gland
0:07
are dominated by pleomorphic adenomas
0:09
and Warthin's tumors. However,
0:11
this is my one teaching file case of an oncocytoma.
0:15
And it shows relatively nicely the finding of a
0:19
vanishing tumor. So here on the T1-weighted scan,
0:22
we see the lesion very nicely,
0:25
and we're going to describe it in the superficial
0:28
portion of the parotid gland.
0:31
We don't see any malignant lymphadenopathy.
0:33
We don't see any approaching of the normal
0:36
appearance of the stylomastoid foramen.
0:40
We look at it on T2-weighted
0:41
scan and it's not lighting up the way a
0:44
pleomorphic adenoma lights up.
0:47
Therefore, we're going to recommend a biopsy.
0:49
If it lights up like a bulb,
0:51
the way pleomorphic adenoma does,
0:53
then we suggest that it's a pleomorphic adenoma
0:55
and the surgeons may go in even without doing
0:58
a biopsy. On the post-gadolinium-enhanced scan,
1:01
we have that phenomenon of the "vanishing tumor."
1:05
So although this enhances slightly more
1:07
than the normal parotid tissue,
1:09
you can see that you lose the conspicuity of the
1:12
lesion, and therefore it seems to be vanishing
1:15
from its T1 appearance.
1:18
And this is the feature that people have
1:21
described with the oncocytoma.
1:25
On the coronal post-gadolinium-enhanced scan,
1:28
we've gotten a little bit more time
1:29
for the tumor to imbibe contrast,
1:31
but nonetheless,
1:34
its contrast with the normally enhancing
1:38
parotid tissue is limited.
1:40
Hence the term "the vanishing parotid tumor"
1:44
equals oncocytoma.
Interactive Transcript
0:01
Oncocytomas are not very common lesions.
0:04
Certainly, the benign lesions of the parotid gland
0:07
are dominated by pleomorphic adenomas
0:09
and Warthin's tumors. However,
0:11
this is my one teaching file case of an oncocytoma.
0:15
And it shows relatively nicely the finding of a
0:19
vanishing tumor. So here on the T1-weighted scan,
0:22
we see the lesion very nicely,
0:25
and we're going to describe it in the superficial
0:28
portion of the parotid gland.
0:31
We don't see any malignant lymphadenopathy.
0:33
We don't see any approaching of the normal
0:36
appearance of the stylomastoid foramen.
0:40
We look at it on T2-weighted
0:41
scan and it's not lighting up the way a
0:44
pleomorphic adenoma lights up.
0:47
Therefore, we're going to recommend a biopsy.
0:49
If it lights up like a bulb,
0:51
the way pleomorphic adenoma does,
0:53
then we suggest that it's a pleomorphic adenoma
0:55
and the surgeons may go in even without doing
0:58
a biopsy. On the post-gadolinium-enhanced scan,
1:01
we have that phenomenon of the "vanishing tumor."
1:05
So although this enhances slightly more
1:07
than the normal parotid tissue,
1:09
you can see that you lose the conspicuity of the
1:12
lesion, and therefore it seems to be vanishing
1:15
from its T1 appearance.
1:18
And this is the feature that people have
1:21
described with the oncocytoma.
1:25
On the coronal post-gadolinium-enhanced scan,
1:28
we've gotten a little bit more time
1:29
for the tumor to imbibe contrast,
1:31
but nonetheless,
1:34
its contrast with the normally enhancing
1:38
parotid tissue is limited.
1:40
Hence the term "the vanishing parotid tumor"
1:44
equals oncocytoma.
Report
Description
Faculty
David M Yousem, MD, MBA
Professor of Radiology, Vice Chairman and Associate Dean
Johns Hopkins University
Tags
Salivary Glands
Neuroradiology
Neoplastic
MRI
Head and Neck
© 2025 Medality. All Rights Reserved.